Literature DB >> 2668160

Genetic control of rat heart allograft rejection: effect of different MHC and non-MHC incompatibilities.

J Klempnauer1, B Steiniger, R Lück, E Günther.   

Abstract

We investigated the genetic control of heterotopic heart allograft rejection using a family of standard inbred, major histocompatibility complex (MHC)-congenic, and intra-MHC recombinant rat strains. Gene products of the various regions within the rat MHC differed markedly in their capacity to induce rejection. Isolated incompatibility at class I antigens encoded by the RTl.A and RTl.C regions failed to induce rejection within the observation period of 100 days, whereas class II antigens encoded by the RTl.B/D region provoked rapid rejection within 10 days. By comparison of the rejection times of isolated and combined incompatibilities a number of functional interactions could be demonstrated between individual MHC regions which either prolonged or shortened allograft survival. In contrast to rapid rejection of MHC-mismatched heart allografts, differences at non-MHC histocompatibility antigens were associated with graft survival beyond 100 days, although chronic rejection of variable severity was detected histologically. Disparity at non-MHC plus class I antigens, however, provoked acute heart allograft rejection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2668160     DOI: 10.1007/bf02421535

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  29 in total

1.  Rejection of murine cardiac allografts. I. Relative roles of major and minor antigens.

Authors:  J F Burdick; L W Clow
Journal:  Transplantation       Date:  1986-07       Impact factor: 4.939

2.  Polymorphism and mapping of the class II genes in the rat: RT1.B, RT1.D, and RT1.H, a new DP-like region.

Authors:  J W Watters; J D Locker; H W Kunz; T J Gill
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  Chronic kidney allograft reactions in rats.

Authors:  E White; W H Hildemann; Y Mullen
Journal:  Transplantation       Date:  1969-11       Impact factor: 4.939

4.  The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in mice.

Authors:  S M Stepkowski; A Raza-Ahmad; W R Duncan
Journal:  Transplantation       Date:  1987-12       Impact factor: 4.939

5.  Phenotype and histological distribution of interstitial dendritic cells in the rat pancreas, liver, heart, and kidney.

Authors:  B Steiniger; J Klempnauer; K Wonigeit
Journal:  Transplantation       Date:  1984-08       Impact factor: 4.939

Review 6.  Genetic control of transplant rejection.

Authors:  G W Butcher; J C Howard
Journal:  Transplantation       Date:  1982-10       Impact factor: 4.939

7.  Genetics of the blood transfusion effect on heart allografts in rats.

Authors:  J P Soulillou; F Blandin; E Günther; V Lemoine
Journal:  Transplantation       Date:  1984-07       Impact factor: 4.939

8.  Serologic and cellular characterization of products of a new major histocompatibility gene region, RT1.C, of the rat; possible homology to mouse H-2 Qa.

Authors:  W Stock; E Günther
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

9.  Participation of H-2 regions in heart-transplant rejection.

Authors:  J Klein; C Chiang; J Lofgreen; D Steinmuller
Journal:  Transplantation       Date:  1976-10       Impact factor: 4.939

10.  Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells.

Authors:  R I Lechler; J R Batchelor
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

View more
  4 in total

1.  Expression profiling of major histocompatibility and natural killer complex genes reveals candidates for controlling risk of graft versus host disease.

Authors:  Peter Novota; Severin Zinöcker; Jean Norden; Xiao Nong Wang; Lisbet Sviland; Lennart Opitz; Gabriela Salinas-Riester; Bent Rolstad; Anne M Dickinson; Lutz Walter; Ralf Dressel
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

2.  Application of allogeneic bone marrow cells in view of residual alloreactivity: sirolimus but not cyclosporine evolves tolerogenic properties.

Authors:  Kai Timrott; Florian W R Vondran; Hueseyin Bektas; Jürgen Klempnauer; Mark D Jäger
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

3.  The importance of MHC class II in allogeneic bone marrow transplantation and chimerism-based solid organ tolerance in a rat model.

Authors:  Kai Timrott; Oliver Beetz; Felix Oldhafer; Jürgen Klempnauer; Florian W R Vondran; Mark D Jäger
Journal:  PLoS One       Date:  2020-05-22       Impact factor: 3.240

4.  Recipient natural killer cells alter the course of rejection of allogeneic heart grafts in rats.

Authors:  Oliver Beetz; Joline Kolb; Benjamin Buck; Britta Trautewig; Kai Timrott; Florian W R Vondran; Ingrid Meder; Corinna Löbbert; Joachim Hundrieser; Jürgen Klempnauer; Hüseyin Bektaş; Thorsten Lieke
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.